Blueshift Asset Management, LLC Gilead Sciences, Inc. Transaction History

Blueshift Asset Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $318,244 - $388,091	4,446 New	4,446 $325,000
Q2 2023 Aug 15, 2023	BUY	$76.01 - $86.7 $161,901 - $184,671	2,130 Added 74.19%	5,001 $385,000
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $221,957 - $252,877	2,871 New	2,871 $238,000
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $2.68 Million - $3.02 Million	-46,496 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$57.92 - $72.58 $2.15 Million - $2.69 Million	37,078 Added 393.69%	46,496 $2.76 Million
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $379,677 - $430,941	5,852 Added 164.11%	9,418 $684,000
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $241,382 - $260,424	3,566 New	3,566 $249,000
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $546,159 - $596,756	-8,605 Closed	0 $0
Q1 2021 May 06, 2021	BUY	$60.0 - $68.46 $516,300 - $589,098	8,605 New	8,605 $556,000
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $631,851 - $695,016	-10,254 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $416,691 - $459,954	6,666 Added 185.79%	10,254 $650,000
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $221,989 - $248,935	3,588 New	3,588 $242,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blueshift Asset Management, LLC with notifications on news.